ICIEM 2017: Long-Term Migalastat Treatment Associated With Sustained Reduction in LVMi and Regression of Left Ventricular Hypertrophy in Patients With Fabry Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.